4 Pharma Majors Invest In ABCD Technologies

New Delhi : Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies LLP which will be renamed as IndoHealth Services LLP. The four pharma majors are investing Rs 40 crore each in the target entity which is a recently incorporated limited liability partnership and has not commenced any business activities, they added.

Sun Pharma and Cadila Healthcare said one of the wholly owned Indian subsidiaries have subscribed to partnership interest in ABCD Technologies LLP.

The objective of the acquisition is to facilitate, enable and promote efficiency and good distribution practices, including digitising healthcare infrastructure in India, inter alia, in support of the National Digital Health Mission of Government of India, the regulatory filings said.

The nature of consideration is cash infusion as capital contribution and Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma are investing Rs 40 crore each in the target entity, they added.

While Sun Pharma and Cadila Healthcare said that Rs 40 crore is for 20 per cent share of profit/ loss in the target entity, Lupin and Torrent Pharma said Rs 40 crore is for up to 20 per cent share of profit/loss in the target entity.

  • Related Posts

    GSK Pharma forays into gynaecological cancer treatment in India

    GlaxoSmithKline Pharmaceuticals Ltd. stock zoomed as much as 2% on Monday, August 25. This movement in shares came after the company announced its entry into the oncology segment in India…

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    Hyderabad:  Chief Minister A Revanth Reddy said Hyderabad was India’s emerging hub of biotech, pharma, and medical technology innovation, with the ambition to become a $1 trillion economy by 2034.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    GSK Pharma forays into gynaecological cancer treatment in India

    GSK Pharma forays into gynaecological cancer treatment in India

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    DCGI issued alert regarding theft of Novo Nordisk injectables

    DCGI issued alert regarding theft of Novo Nordisk injectables

    Two firms fined for selling spurious cosmetic products

    Two firms fined for selling spurious cosmetic products